Fundz

D2 G Oncology, Inc. reported raising $6.57 Million in an initial SEC Form D filing, from an offering of $7.25 Million

PRIVATEFeb 28, 2020$6.6M of $7.3M raised

Amount Raised

$6.57 Million

$6.57 Million sold, per SEC Form D (first sale Feb 28, 2020)

Round Type

Venture

Mountain ViewBiotechnology

Quick answer

D2G Oncology, Inc. raised $6.57 Million in a funding round, dated February 28, 2020. D2G Oncology, Inc. is based in Mountain View, California, United States.

How much did D2G Oncology, Inc. raise?
D2G Oncology, Inc. raised $6.57 Million in a funding round on February 28, 2020.
What does D2G Oncology, Inc. do?
D2G Oncology is relating drugs to genotypes to transform precision cancer therapeutics
Where is D2G Oncology, Inc. based and how big is it?
D2G Oncology, Inc. is based in Mountain View, California, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as D2G Oncology, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Halo Labs raised $6.7M on April 13, 2020.
  • Stealth BioTherapeutics Corp raised $20M on April 13, 2020.
  • Embody raised $9.3M on April 10, 2020.
  • Crispr Therapeutics raised $1M (Seed) on April 9, 2020.
  • iTeos Therapeutics, Inc. raised $125M on April 9, 2020.
  • EternaTear, Inc. raised $2.2M (Seed) on April 9, 2020.

Who to call at D2G Oncology, Inc., and when

A new round usually means D2G Oncology, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day D2G Oncology, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at D2G Oncology, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at D2G Oncology, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

D2G Oncology, Inc.

Location

297 N. BERNARDO AVENUE

Mountain View, California, United States

About

D2G Oncology is relating drugs to genotypes to transform precision cancer therapeutics

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment D2G Oncology, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for D2G Oncology, Inc.'s next move

See what Strategic adds

D2G Oncology, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.